ATM and lung carcinoma: MiR-18-5p was reported to be a potential target for improving radiosensitivity in lung cancer by regulating the ataxia telangiectasia mutated (ATM) gene and hypoxia-inducible factor 1 alpha (HIF-1α) gene [136].